Text Size
Trial record 1 of 4 for:    "Alpha-Thalassemia"
Previous Study | Return to List | Next Study

Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by HaEmek Medical Center, Israel.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00971984
First received: September 3, 2009
Last updated: September 10, 2009
Last verified: September 2009
History of Changes
  Purpose

The study intends to summarize the clinical and laboratory characteristics of children with hemolytic anemia diagnosed as having alpha thalassemia mutations.


Condition Intervention
Thalassemia Alpha
Hemolytic Anemia
 Other: Medical records summary

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

Resource links provided by NLM:

MedlinePlus related topics: Anemia Thalassemia
U.S. FDA Resources

Further study details as provided by HaEmek Medical Center, Israel:

Estimated Enrollment: 50
Study Start Date: October 2009
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Alpha thalassemia patients
Patients diagnosed with alpha thalassemia mutations and anemia
 Other: Medical records summary
Summary of Medical files and laboratory results.

Detailed Description:

Fifty children and adolescents diagnosed as having alpha thalassemia will be studied, the clinical characteristics and hematology analysis will be summarized.

  Eligibility

Ages Eligible for Study:   up to 20 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

A group of 50 children that underwent workup due to hemolytic anemia and were further diagnosis as suffering from clinical alpha thalassemia.

Criteria

Inclusion Criteria:

  • All the patients that were studied at the pediatric hematology unit ant the Ha'Emek Medical Center

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00971984

Locations
Israel
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center Not yet recruiting
Afula, Israel, 18101
Contact: Ariel Koren, MD     972-4-6495576 ext 5576     koren_a@clalit.org.il    
Sub-Investigator: Ariel Koren, MD            
Principal Investigator: Carina Levin, MD            
Principal Investigator: Keren Nathan, Student            
Sponsors and Collaborators
HaEmek Medical Center, Israel
  More Information

No publications provided

Responsible Party: Dr Koren Ariel, Pediatric Hematology Unit and Pediatric Dpt B, Ha'Emek Medical Center, Afula, Israel
ClinicalTrials.gov Identifier: NCT00971984     History of Changes
Other Study ID Numbers: 0074-09-EMC
Study First Received: September 3, 2009
Last Updated: September 10, 2009
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Alpha-Thalassemia
Anemia
Anemia, Hemolytic
Thalassemia
Hemolysis
 Anemia, Hemolytic, Congenital
Hematologic Diseases
Hemoglobinopathies
Genetic Diseases, Inborn
Pathologic Processes

ClinicalTrials.gov processed this record on May 22, 2013